Original Article

Knowledge of and technique for using inhalation devices among asthma patients and COPD patients

Técnica e compreensão do uso dos dispositivos inalatórios em pacientes com asma ou DPOC

Maria Luiza de Moraes Souza, Andrea Cristina Meneghini, Érica Ferraz, Elcio Oliveira Vianna, Marcos Carvalho Borges

J Bras Pneumol.2009;35(9):824-831

Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications

Atenção farmacêutica ao portador de asma persistente: avaliação da aderência ao tratamento e da técnica de utilização dos medicamentos inalatórios

Daiane de Oliveira Santos, Maria Cleusa Martins, Sonia Lucena Cipriano, Regina Maria Carvalho Pinto, Alberto Cukier, Rafael Stelmach

J Bras Pneumol.2010;36(1):14-22

Use of inhaler devices and asthma control in severe asthma patients at a referral center in the city of Salvador, Brazil

Manuseio de dispositivos inalatórios e controle da asma em asmáticos graves em um centro de referência em Salvador

Ana Carla Carvalho Coelho, Adelmir Souza-Machado, Mylene Leite, Paula Almeida, Lourdes Castro, Constança Sampaio Cruz, Rafael Stelmach, Álvaro Augusto Cruz

J Bras Pneumol.2011;37(6):720-728

Quality of Communication Questionnaire para pacientes com DPOC em cuidados paliativos: tradução e adaptação cultural para uso no Brasil

Flávia Del Castanhel1, Suely Grosseman2

J Bras Pneumol.2017;43(5):357-362

Risk for Mycobacterium tuberculosis infection among medical students at the Universidade Federal do Rio de Janeiro Faculdade de Medicina

Risco de infecção pelo Mycobacterium tuberculosis entre alunos da Faculdade de Medicina da Universidade Federal do Rio de Janeiro

Vania Maria Carneiro da Silva, Antônio José Ledo Alves da Cunha, Afrânio Lineu Kritski

J Bras Pneumol.2004;30(5):459-466

Pneumonia por "Pneumocystis carinii" em pacientes com e sem SIDA: reavaliação

"Pneumocystis carinii" pneumonia in patients with and without AIDS: a reappraisal

Carloss Viegas, Ronald FCCP, Collman G

J Bras Pneumol.1997;23(2):79-82

Review Article

Dysfunctional breathing: what do we know?

Disfunção respiratória: o que sabemos?

Laís Silva Vidotto1,a, Celso Ricardo Fernandes de Carvalho2,b, Alex Harvey1,c, Mandy Jones1,d

J Bras Pneumol.2019;45(1):e20170347

Editorial

Smoking in adolescence: Why do youths still smoke?

Tabagismo na adolescência: Por que os jovens ainda fumam?

Alberto José de Araújo

J Bras Pneumol.2010;36(6):671-673

Index of Issues

Índice remissivo de assuntos do volume 44 (1-6) 2018

J Bras Pneumol.2018;44(6):533-534

Index of Authors

Índice remissivo de autores do volume 44 (1-6) 2018

J Bras Pneumol.2018;44(6):535-538

List of reviewers

Relação de revisores do volume 44 (1-6) 2018

J Bras Pneumol.2018;44(6):539-542

Continuing Education : Scientific Methodology

Critical appraisal of the literature. Why do we care?

Avaliação crítica da literatura. Por que nos importamos?

Juliana Carvalho Ferreira1,2,a, Cecilia Maria Patino1,3,b

J Bras Pneumol.2018;44(6):448

Editorial

Anti-alarmin asthma therapies: where do we go from here?

Terapias antialarminas para a asma: para onde vamos a partir daqui?

Ibrahim Sulaiman1, Gail M Gauvreau2

J Bras Pneumol.2023;49(3):e20230220

Letters to the Editor

Pharmacological approach to iatrogenic bleeding during bronchoscopy: what do we know so far and where do we go from here?

Abordagem farmacológica do sangramento iatrogênico durante a broncoscopia: o que sabemos até agora e para onde vamos a partir daqui?

Ana Alfaiate1, Vera Clérigo2, David Noivo1, Lígia Fernandes2, Paula Duarte1

J Bras Pneumol.2023;49(2):e20220195

Original Article

Smoking and alcohol drinking practices among employees of Universidade Estadual do Ceará

Tabagismo e etilismo em funcionários da Universidade Estadual do Ceará

Maria Olganê Dantas Sabry, Helena Alves de Carvalho Sampaio, Marcelo Gurgel Carlos da Silva

J Bras Pneumol.1999;25(6):313-320

Cigarette smoking survey among physicians of Rio Grande, Rio Grande do Sul: prevalence and smoker's profile

Pesquisa sobre tabagismo entre médicos de Rio Grande, RS: prevalência e perfil do fumante

Luís Suárez Halty, Maura Dumont Hüttner, Isabel de Oliveira Netto, Thaís Fenker, Tatiana Pasqualini, Berenice Lempek, Adriana Santos, Alessandra Muniz

J Bras Pneumol.2002;28(2):77-83

Mortality due to idiopathic pulmonary fibrosis in the State of Rio Grande do Sul (Brazil)

Mortalidade por fibrose pulmonar idiopática no Rio Grande do Sul

Fabrício Picolli Fortuna, Christiano Perin, Letícia Cunha, Adalberto Sperb Rubin

J Bras Pneumol.2003;29(3):121-124

Prevalence of Streptococcus pneumoniae resistance to penicillin in two hospital from Caxias do Sul

Prevalência de resistência à penicilina do Streptococcus pneumoniae em dois hospitais de Caxias do Sul

Wilson Paloschi Spiandorello, Fernanda Morsch, Franca Stedile Angeli Spiandorello

J Bras Pneumol.2003;29(1):15-20

Drug resistance profile of Mycobacterium tuberculosis in the state of Mato Grosso do Sul, Brazil, 2000-2006

Perfil de resistência de Mycobacterium tuberculosis no estado de Mato Grosso do Sul, 2000-2006

Marli Marques, Eunice Atsuko Totumi Cunha, Antonio Ruffino-Netto, Sonia Maria de Oliveira Andrade

J Bras Pneumol.2010;36(2):224-231

Objective: To determine the drug resistance profile of Mycobacterium tuberculosis in the state of Mato Grosso do Sul, Brazil, between 2000 and 2006. Methods: Descriptive study of reported tuberculosis cases in the Brazilian Case Registry Database. We included only those cases in which M. tuberculosis culture was positive and sensitivity to drugs (rifampicin, isoniazid, streptomycin and ethambutol) was tested. Löwenstein-Jensen and Ogawa-Kudoh solid media were used for cultures, as was an automated liquid medium system. Sensitivity tests were based on the proportion method. Results: Among the 783 cases evaluated, males predominated (69.7%), as did patients in the 20-49 year age bracket (70%), a diagnosis of pulmonary tuberculosis (94.4%) and positive HIV serology (8.6%); 645 (82.4%) were new cases, and 138 (17.6%) had previously been treated. Resistance to at least one drug was found in 143 cases (18.3%). The primary resistance (PR) rate was, respectively, 8.1%, 1.6%, 2.8% and 12.4%, for monoresistance, multidrug resistance (MDR), other patterns of resistance and resistance to at least one drug, whereas the acquired resistance (AR) rate was 14.5%, 20.3%, 10.9% and 45.7%, respectively, and the combined resistance (CR) rate was 9.2%, 4.9%, 4.2% and 18.3%, respectively. In PR, streptomycin was the most common drug, whereas isoniazid was the most common in AR and CR (7.2% and 3.7%, respectively). Conclusions: These high levels of resistance undermine the efforts for tuberculosis control in Mato Grosso do Sul. Acquired MDR was 12.7 times more common than was primary MDR, demonstrating that the previous use of drug therapy is an indicator of resistance. These levels reflect the poor quality of the health care provided to these patients, showing the importance of using the directly observed treatment, short course strategy, as well as the need to perform cultures and sensitivity tests for the early diagnosis of drug resistance.

Keywords: Tuberculosis; Drug resistance, multiple; Mycobacterium tuberculosis.

Asthma and atopy prevalence in a group of students from Porto Alegre, Rio Grande do Sul

Variação na prevalência de asma e atopia em um grupo de escolares de Porto Alegre, Rio Grande do Sul

Renata Wagner Fiore, Adriana Barbieri Comparsi, Cláudia Loss Reck, Jéferson Krawcyk de Oliveira, Karina Brasco Pampanelli, Carlos Cezar Fritscher

J Bras Pneumol.2001;27(5):237-242

Search Results

Original Article

Review Article

Editorial

Index of Issues

Index of Authors

List of reviewers

Continuing Education : Scientific Methodology

Editorial

Letters to the Editor

Original Article

Anos

Seções

Indexes

Official publication

Newsletters